Hibernating myocardium: diagnosis and patient outcomes

Arend F L Schinkel1, Jeroen J Bax, Don Poldermans

  • 1Cardiology, Thoraxcenter, Rotterdam, The Netherlands.

Insights

Approximately half of patients with coronary artery disease experience hibernating myocardium, a condition that may improve with revascularization. This analysis compares imaging techniques for diagnosing hibernating myocardium and predicting patient outcomes.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Diagnostic Imaging

Background:

  • Chronic obstructive coronary artery disease frequently leads to chronic contractile dysfunction.
  • Hibernating myocardium, present in about 50% of these patients, indicates potential for functional recovery.
  • Revascularization strategies may benefit patients with hibernating myocardium.

Purpose of the Study:

  • To compare the diagnostic accuracy of various imaging modalities for identifying hibernating myocardium.
  • To evaluate the predictive value of these techniques for patient outcomes.
  • To inform clinical decision-making regarding revascularization in coronary artery disease.

Main Methods:

  • Pooled analysis of studies evaluating imaging techniques.
  • Inclusion of dobutamine echocardiography, thallium-201 scintigraphy, technetium-99m scintigraphy, positron emission tomography (PET), and magnetic resonance imaging (MRI).
  • Assessment of diagnostic performance and prognostic capabilities.

Main Results:

  • The study comparatively analyzes the effectiveness of different imaging modalities.
  • Relative merits for diagnosing hibernating myocardium are described.
  • Predictive accuracy for patient outcomes is assessed across techniques.

Conclusions:

  • Specific imaging modalities demonstrate varying degrees of success in diagnosing hibernating myocardium.
  • The choice of imaging technique can influence the prediction of patient outcomes.
  • Findings support the use of advanced imaging for guiding revascularization decisions.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...